ClassID:

94052

C07D207/04 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members

Sub-classes:
Recent Application in this class:
#1
20260132107
2026-05-14

METHOD OF PREPARING IONIC FLUIDS

#2
20250345446
2025-11-13

BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES

#3
20250341490
2025-11-06

ELECTROLYTE FOR ELECTROCHEMICAL GAS SENSOR AND ELECTROCHEMICAL GAS SENSOR INCLUDING THE SAME

#4
20250304549
2025-10-02

HYDROXYAMIDE DERIVATIVE AND USE THEREOF

#5
20250296935
2025-09-25

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

#6
20250282808
2025-09-11

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#7
20250236586
2025-07-24

LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF ACTIVE AGENTS

#8
20250188027
2025-06-12

PROCESS FOR THE PRODUCTION OF A TERTIARY AMINE SURFACTANT

#9
20250120944
2025-04-17

ANTIBACTERIAL COMPOSITION

#10
20240352067
2024-10-24

PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME

#11
20240327340
2024-10-03

SMALL MOLECULE COMPOUNDS HAVING NAPHTHYLAMINE STRUCTURE AND APPLICATION THEREOF

#12
20240294467
2024-09-05

USP9X inhibitors

#13
20240226287
2024-07-11

NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME

#14
20240158346
2024-05-16

METHOD OF PREPARING IONIC FLUIDS

#15
20240108744
2024-04-04

AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

#16
20230345986
2023-11-02

CONJUGATED DIYNES AND THEIR USE AS FLAVOR MODIFIERS

#17
20230250104
2023-08-10

Diamine derivatives as inhibitors of leukotriene Ahydrolase

#18
20230212211
2023-07-06

Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease

#19
20230133011
2023-05-04

MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES

#20
20230123534
2023-04-20

Lipids for lipid nanoparticle delivery of active agents

#21
20230041069
2023-02-09

ELECTROLYTE FOR ELECTROCHEMICAL GAS SENSOR AND ELECTROCHEMICAL GAS SENSOR INCLUDING THE SAME

#22
20230018246
2023-01-19

PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME

#23
20220396583
2022-12-15

COMPOUNDS AS MODULATORS OF TLR2 SIGNALING

#24
20220315554
2022-10-06

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

#25
20210061783
2021-03-04

Synthetic nicotine composition

#26
20210024539
2021-01-28

Compounds as modulators of TLR2 signaling

#27
20200385344
2020-12-10

Compounds and pharmaceutical composition associated with ubiquitination-proteasome system

#28
20200308181
2020-10-01

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#29
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#30
20200283372
2020-09-10

Lipids for lipid nanoparticle delivery of active agents

#31
20200207797
2020-07-02

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#32
20200190019
2020-06-18

PPAR agonists

#33
20200031808
2020-01-30

Process for synthesis of eliglustat and intermediate compounds thereof

#34
20190388391
2019-12-26

NOVEL ERYTHROMELALGIA TREATMENT

#35
20190335745
2019-11-07

Compositions for organ preservation

#36
20190276474
2019-09-12

CHIMERIC COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF

#37
20190269652
2019-09-05

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor

#38
20190256365
2019-08-22

EMM-37 materials and processes and uses thereof

#39
20190218106
2019-07-18

EMM-28, a novel synthetic crystalline material, its preparation and use

#40
20190211267
2019-07-11

Lysine and proline based flame retardants

#41
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#42
20190169217
2019-06-06

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#43
20190144383
2019-05-16

Compounds and pharmaceutical composition associated with ubiquitination-proteasome system

#44
20190106631
2019-04-11

Lysine and proline based flame retardants

#45
20190084922
2019-03-21

Quaternized ammonium salts of hydrocarbyl epoxides and use thereof as additives in fuels and lubricants

#46
20180354960
2018-12-13

Biphenyl compound or salt thereof

#47
20180230167
2018-08-16

Chimeric compounds targeting proteins, compositions, methods, and uses thereof

#48
20180230159
2018-08-16

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#49
20180223203
2018-08-09

Cyclic quaternary ammonium salts as fuel or lubricant additives

#50
20180208625
2018-07-26

Method for preventing, improving, or treating inflammatory bowel disease

#51
20180170857
2018-06-21

PPAR agonists

#52
20180169037
2018-06-21

Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles

#53
20180022697
2018-01-25

Glucosylceramide synthase inhibitors and therapeutic methods using the same

#54
20170368029
2017-12-28

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

#55
20170334932
2017-11-23

Chimeric compounds targeting proteins, compositions, methods, and uses thereof

#56
20170333443
2017-11-23

Chimeric compounds targeting proteins, compositions, methods, and uses thereof

#57
20170312252
2017-11-02

Pyrrolidine amide compounds as histone demethylase inhibitors

#58
20170304264
2017-10-26

Erythromelalgia treatment

#59
20170290818
2017-10-12

Compounds alpha v beta 6 integrin antagonists

#60
20170197915
2017-07-13

Estrogen receptor modulators and uses thereof

#61
20170182486
2017-06-29

Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations

#62
20170158521
2017-06-08

EMM-28, a novel synthetic crystalline material, its preparation and use

#63
20170121367
2017-05-04

Agonists of neurotrophin receptors and their use as medicaments

#64
20160362376
2016-12-15

Sulfonamide derivative or pharmaceutically acceptable acid addition salt thereof

#65
20160326095
2016-11-10

One-pot water-free ionic liquids synthesis using trialkyl orthoesters

#66
20160304450
2016-10-20

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

#67
20160272585
2016-09-22

Phenoxyethyl cyclic amine derivatives and their activity as EP4 receptor modulators

#68
20160206578
2016-07-21

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

#69
20160131972
2016-05-12

Onium salt compound, resist composition, and pattern forming process

#70
20160052863
2016-02-25

PROCESS FOR PRODUCING AN AMINOPROPYNE OR ENAMINONE

#71
20160023991
2016-01-28

PPAR agonists

#72
20150315140
2015-11-05

Process for preparing amines

#73
20150266815
2015-09-24

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

#74
20150266808
2015-09-24

Quaternized ammonium salts of hydrocarbyl epoxides and use thereof as additives in fuels and lubricants

#75
20150158020
2015-06-11

SYNTHESIS OF ZEOLITES USING AN ORGANOAMMONIUM COMPOUND

#76
20150080382
2015-03-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#77
20150031726
2015-01-29

Substituted phenylcarbamoyl alkylamino arene compounds and N,N′-BIS-arylurea compounds

#78
20150005239
2015-01-01

Agonists of neurotrophin receptors and their use as medicaments

#79
20140323412
2014-10-30

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#80
20140235873
2014-08-21

Process for producing ionic liquids

#81
20140193707
2014-07-10

Sulfur-containing additives for electrochemical or optoelectronic devices

#82
20140142322
2014-05-22

Boronic acid catalysts and methods of use thereof for activation and transformation of carboxylic acids

#83
20130274240
2013-10-17

Fluorene compound and pharmaceutical use thereof

#84
20130245018
2013-09-19

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

#85
20130196013
2013-08-01

Chemical and biological agents for the control of molluscs

#86
20130121978
2013-05-16

Chemical and biological agents for the control of molluscs

#87
20130112923
2013-05-09

Composition and method for inhibiting gas hydrate formation

#88
20130108573
2013-05-02

Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease

#89
20130079372
2013-03-28

Substituted phenylcarbamoyl alkylamino arene compounds and N,N'-BIS-arylurea compounds

#90
20120316169
2012-12-13

2-ARYL-PROPIONAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

#91
20120232292
2012-09-13

Process for the preparation of primary amines by homogeneously catalyzed alcohol amination

#92
20120232278
2012-09-13

Insecticidal aryl pyrrolidines

#93
20120052094
2012-03-01

Agonists of neurotrophin receptors and their use as medicaments

#94
20110313159
2011-12-22

Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same

#95
20110251164
2011-10-13

Carboxamide derivatives as muscarinic receptor antagonists

#96
20110172189
2011-07-14

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

#97
20110111068
2011-05-12

Inhibitors of cognitive decline

#98
20110098334
2011-04-28

Crystalline form of zofenopril calcium

#99
20110082175
2011-04-07

Insecticidal aryl pyrrolidines

#100
20110015152
2011-01-20

Diarylmethyl and related compounds

#101
20100266717
2010-10-21

CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS

#102
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#103
20100210630
2010-08-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#104
20100104629
2010-04-29

CATIONIC LIPIDS AND USES THEREOF

#105
20100029720
2010-02-04

Carboxamide derivatives as muscarinic receptor antagonists

#106
20090253905
2009-10-08

PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT

#107
20080306084
2008-12-11

Substituted amide compounds

#108
20080193574
2008-08-14

Inhibitors of cognitive decline

#109
20080114030
2008-05-15

Diarymethyl and related compounds

#110
20080108820
2008-05-08

Hemiasterlin Derivatives and Uses Thereof

#111
20070235696
2007-10-11

Preparation and purification of ionic liquids and precursors

#112
20070155727
2007-07-05

Amide inhibitors of leukotriene A4 hydrolase

#113
20070155726
2007-07-05

Diamine derivatives as inhibitors of leukotriene Ahydrolase

#114
20070142450
2007-06-21

Novel urea derivatives and their medical use

#115
20070105831
2007-05-10

Carboxamide derivatives as muscarinic receptor antagonists

#116
20060287369
2006-12-21

Diarylmethyl and related compounds

#117
20060167244
2006-07-27

Polymerisation inhibitor

#118
20060154872
2006-07-13

Hemiasterlin derivatives and uses thereof

#119
20050250814
2005-11-10

Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity

#120
20050171181
2005-08-04

Histamine-3 receptor modulators

#121
20050070719
2005-03-31

Inhibitors of dipeptidyl peptidase iv

#122
20050000791
2005-01-06

Process for fractionating water-containing crude amine mixtures from amine synthesis

#123
17983873
2023-11-28

Method of preparing ionic fluids

#124
15681716
2018-06-05

Process for synthesis of Eliglustat and intermediate compounds thereof